Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Competition
Pharma
Teva hit with €463M fine over Copaxone misconduct claims in EU
The European Commission fined Teva 462.6 million euros over claims that it “[abused] its dominant market position to delay competition” to Copaxone.
Fraiser Kansteiner
Oct 31, 2024 10:45am
Roche CEO critiques Novo's proposed Catalent buyout
Oct 23, 2024 12:35pm
EU authorities fine Boehringer, others for operating 'cartel'
Oct 23, 2023 10:13am
Gilead, Teva and J&J's HIV antitrust case inches closer to trial
Feb 22, 2023 3:50pm
